Cempra to Present Anti-NASH Data for Solithromycin at The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cempra to Present Anti-NASH Data for Solithromycin at The Liver Meeting(R) 2015

CHAPEL HILL, N.C., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq: CEMP ), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced it will present research data in a late-breaking poster session at The Liver Meeting ® 2015, organized by the American Association for the Study of Liver Diseases' (AASLD), November 13-17, 2015 to be held at the Moscone West Convention Center in San Francisco.

The presentation will take place during the Acute Liver Failure and Artificial Liver Support session, Poster Session IV, on November 17, 2015 from 8:00 a.m. to 12:00 p.m. PT.

  • "Mechanism of Action of the Anti-NASH effects of Solithromycin in a Predictive NASH HCC Mouse Model" – abstract number 2246. Pierre M. Gholam, M.D. and David Oldach, M.D., will be in attendance from 10:30 a.m. until noon.

About Cempra, Inc.

Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin (CEM-101) has successfully completed two Phase 3 clinical trials for community-acquired bacterial pneumonia (CABP) and is licensed to strategic commercial partner Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation, for certain exclusive rights in Japan. Solithromycin is also in a Phase 3 clinical trial for uncomplicated bacterial urethritis caused by Neisseria gonorrhoeae and chlamydia. Cempra is contracted with BARDA for the development of solithromycin for pediatric use. Three formulations, intravenous, oral capsules and a suspension formulation are in a Phase 1b trial in children from birth to 17 years of age. Taksta™ is Cempra's second product candidate, which is being developed for acute bacterial skin and skin structure Infections (ABSSSI) and is also expected to be tested in an exploratory study for chronic oral treatment of refractory infections in bones and joints. Both products seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. Cempra has also synthesized novel macrolides for non-antibiotic uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Cempra was founded in 2006 and is headquartered in Chapel Hill, N.C. For additional information about Cempra please visit www.cempra.com .

Investor Contact: Robert H. Uhl Westwicke Partners, LLC (858) 356-5932 Media Contact: Tony Plohoros 6 Degrees (908) 591-2839

Scroll down for more posts ▼

Top 10 Most Recent News Articles

k-ID's Kai SDK: Age-Adaptive Design Revolution

Updated Category News Views 48

New Horizons for Developers Today, if you're building an app, you're just as likely to be wrangling with legal regulations as you are writing code. That's where k-ID’s new SDK, Kai, comes into play—it's not just another tool in the shed, it’s the whole toolbox for dealing with age-specific app requirements everywhere. The Changing App Landscape Why does this matter?...

Continue Reading
Qloo's AI Reveals Overlooked EV Market Opportunities

Updated Category News Views 77

Uncovering Surprising Market Overlaps Ever thought the guy barreling through mud in his rugged 4x4 might have more in common with an electric vehicle enthusiast than we'd usually guess? That's the curveball Qloo and Kearney are tossing at us. Their latest study shakes up the tired old assumptions floating around the automotive sector about who's buying what and why. Using...

Continue Reading
Epson Innovates Order Pickup at Florida Food Hall

Updated Category News Views 126

Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...

Continue Reading
Beta Bionics Faces Class Action Over iLet Device Concerns

Updated Category News Views 69

Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 57

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
Ensign Group Faces Securities Fraud Lawsuit Amid Scandal

Updated Category News Views 92

Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...

Continue Reading
Billd's Flex Line: Game-Changer for Subcontractor Credit

Updated Category News Views 103

Billd's Bold Move Across America Forget piecemeal rollouts; Billd's taking their latest brainchild, Flex Line, right into the heart of America's subcontractor landscape. This isn't some flash-in-the-pan financial offering, either—it's a heavy-hitter poised to shake up the way subcontractors wrangle their working capital. We're talking about a line of credit that's as...

Continue Reading
SK hynix Hits $104 Trillion in Revenue, Boosts Dividends

Updated Category News Views 10

Phenomenal Financial Benchmark You gotta give it to SK hynix. They've just blown past that 100 trillion won ceiling like it's a minor bump on the highway. For folks tracking big numbers in memory semiconductors, this is fireworks-worthy. We're talking 104.6155 trillion won in revenue, a solid 83.3338 trillion won in operating profit, and a 39.7756 trillion won net profit....

Continue Reading
Johnson Controls FY26 Results Highlight Growth Momentum

Updated Category News Views 212

Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...

Continue Reading

Top 5 Most Recently Viewed Articles

US National Debt Surpasses $38 Trillion: Key Insights Ahead

Updated Category News Views 302

US National Debt Surges Past $38 Trillion As the federal government encounters a shutdown, the U.S. gross national debt has topped $38 trillion, according to the latest Treasury data, causing widespread concern over the country's financial health. Rapid Escalation of Debt Since 2000 This increase in debt represents the fastest rise outside the COVID-19 pandemic period....

Continue Reading
Guardian Metal Resources Unearths High-Grade Tungsten Finds

Updated Category News Views 276

Guardian Metal Resources Excels in Tungsten Discovery Guardian Metal Resources plc (LON:GMET, OTCQX:GMTLF) is making waves in the mineral exploration world with impressive tungsten assay results from its Pilot Mountain project. Based in Nevada, this company specializes in uncovering valuable mineral resources, and their latest findings showcase not only their commitment...

Continue Reading
West Cancer Center Pioneers Holographic Patient Consultations

Updated Category News Views 152

West Cancer Center Introduces Innovative Holographic Consultations West Cancer Center & Research Institute has teamed up with Proto Inc. to launch an exciting new initiative: the first-ever holographic consultations between doctors and patients. This groundbreaking achievement was unveiled at a prominent event at UC Berkeley, which centered on Global Healthcare...

Continue Reading
PJT Partners Achieves Record Stock Price with Strong Growth

Updated Category News Views 75

PJT Partners Hits All-Time High Stock Price PJT Partners Inc. has reached the impressive milestone of a stock price soaring to an all-time high of $137.24. This remarkable achievement exhibits the confidence investors have in this global advisory-focused investment bank. Over the past year, PJT Partners has experienced an extraordinary 75.12% increase in its stock value,...

Continue Reading
Wyndham Hotels & Resorts Welcomes New Director Alexandra Jung

Updated Category News Views 140

Wyndham Hotels & Resorts Welcomes New Addition to Board Wyndham Hotels & Resorts, a prominent name in the hospitality industry, recently announced the exciting appointment of Alexandra A. Jung to its Board of Directors. This decision highlights the company's commitment to enhancing its governance and operational effectiveness. About Alexandra A. Jung Alexandra A. Jung...

Continue Reading